012sek
-3,6 %
Date:2024-05-03Time:10:50:50Latest report:Q4-2023List:First NorthTicker:SIMRIS B
Market Cap:42 msekEnterprise Value:36 msekNet Sales:4,35 msekEarnings:-37,3 msekEmployees:0ISIN:SE0008091664
Ratios
10-year key figure history for Simris Alg turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Simris Alg with index and moving average MA50 and MA200.
Stockprice:0,12
MA50:0,15
MA200:0,23
Price/MA200:-47,6 %
RSI (14):38,6
Price/MA50:-20,7 %
Description
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.